Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Feb 8, 03:55 AM 2012 
  NYSE  8069.71    NASDAQ  2904.08  
 and more..
Search
sponsered by
  
  



Processing
Collecting necessary data for SLXP and MTEX...
    
  Salix Pharmaceuticals Ltd.  and    Mannatech Incorporated
        
    
Diversification
Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Salix Pharmaceuticals Ltd. and Mannatech Incorporated in the same portfolio (assuming nothing else is changed)
    
    
Correlation Coefficient
-0.03
 Parameters
Time Period1 Month [change]
DirectionNegative SLXP Moved Down vs MTEX
StrengthInsignificant
Accuracy91.3%
ValuesDaily Returns
    
    

       

Salix Pharmaceuticals Ltd.

    
    
48.43
  
Salix Quote
Intraday
 
Salix Intraday Quote
One Month
 0.00   No Change   0.00%  
SLXP Macroaxis: United States NASDAQ
Salix Pharmaceuticals Ltd.
P/E37.25LowNot Applicable
P/B Ratio5.96Market Cap2.864B
SectorHealthcareLast Close48.43
Short Ratio7.80Last Traded2/7/2012
Year High50.28Change (%)Not Applicable
EBITDA142.7MYear Low25.64
Book Value8.127EPS1.30
PEG Ratio0.94Employees390
Target Price54.27Current EPS1.30
This Year EPS2.53Next Year EPS2.78
Current PE37.25This Year PE19.14
Next Year PE17.42DividendNot Applicable
  

Mannatech Incorporated

    
    
4.52
  
Mannatech Quote
Intraday
 
Mannatech Intraday Quote
One Month
 0.00   No Change   0.00%  
MTEX Macroaxis: United States NASDAQ
Mannatech Incorporated
P/B Ratio0.42Market Cap12.0M
SectorConsumer GoodsLast Close4.52
Short Ratio55.60Last Traded2/7/2012
Year High21.50Change (%)Not Applicable
EBITDA-2.5MYear Low3.80
Book Value10.711EPS-6.20
Employees490HighNot Applicable
Target Price20.00Current EPS-6.20
Dividend Date29-Jun-09